RYVU THERAPEUTICS S.

RVU
Delayed Warsaw Stock Exchange - 12:05 2022-11-30 pm EST
54.90 PLN +26.50%

Turn to zoom
Prev.54.90000000
Open51.00000000
High54.90000000
Low48.20000000
Volume102 938
Latest news
14h ago
18h ago
19h ago
6d ago
Chart RYVU THERAPEUTICS S.A.
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishNeutral
Resistance56,456,461,0
Spread/Res.-2,7%-2,7%-10%
Spread/Supp.26%53%142%
Support43,436,022,7
Financials
Sales 2022 43,0 M 9,49 M 9,49 M
Net income 2022 -86,4 M -19,1 M -19,1 M
Net cash 2022 26,0 M 5,74 M 5,74 M
P/E ratio 2022 -
Yield 2022 -
Capitalization 1 008 M 222 M 222 M
EV / Sales 2022 22,8x
EV / Sales 2023 32,1x
Nbr of Employees -
Free-Float 74,3%
Company
Ryvu Therapeutics SA, formerly known as Selvita SA, is a Poland-based company engaged in the healthcare industry. The Company is active in the pharmaceutical and biotechnology fields. It operates through two business segments. The Innovative segment develops new drugs mainly for oncology and...
Sector :
Bio Therapeutic Drugs
Calendar :
2022-12-10 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 54,90 PLN
Average target price 55,70 PLN
Spread / Average Target 1,46%